Peer Review History
| Original SubmissionMay 8, 2020 |
|---|
|
PONE-D-20-13596 Added diagnostic values of three-dimensional high-resolution proton density-weighted magnetic resonance imaging for unruptured intracranial aneurysms in the circle-of-Willis: Comparison with time-of-flight magnetic resonance angiography. PLOS ONE Dear Dr. Jung, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== This manuscript was evaluated with substantial criticism, in particular with regards of omission of important recent references of very similar studies on PD imaging of intracranial aneurysms by Korean groups: 1. Kim S, Chung J, Cha J, et al. Usefulness of high-resolution three-dimensional proton density-weighted turbo spin-echo MRI in distinguishing a junctional dilatation from an intracranial aneurysm of the posterior communicating artery: a pilot study. Journal of NeuroInterventional Surgery 2020;12:315-319 2. Seon Jin Yoon, Na-Young Shin, Jae Whan Lee, Seung Kon Hu and Keun Young Park. Localization and Treatment of Unruptured Paraclinoid Aneurysms: A Proton Density MRI-based Study. J Cerebrovasc Endovasc Neurosurg. 2015;17(3):180-184 There appears to be a serious concern of dual publication of data and it appears unclear whether these are publications from the same group or not. It is not understandable why the authors did not mention these publications from colleagues on the same topic! So we cannot accept this paper in PLOS ONE if the authors do not make clear that: 1. there is no overlap in analyzed patient cohorts between their study submitted to our journal and the other two studies published in different journal. 2. what the added values and differences in methods, analyzed endpoints/variables and results between their submitted studied and the two previously published studies was! In addition, please answer all other comments from both authors and modify your manuscript accordingly. However, we cannot guarantee any publication if the major issue of potential dual publication cannot be solved convincingly by your answer. ============================== Please submit your revised manuscript by Aug 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Stephan Meckel, MD, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please clarify in your Data availability statement how other researchers can obtain the same dataset. For PLOS ONE data sharing guidelines, please see " ext-link-type="uri" xlink:type="simple">https://journals.plos.org/plosone/s/data-availability" 3. Thank you for including your ethics statement: "This retrospective study was approved by our institutional review board, which waived the requirement for informed consent. ". i) Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study. ii) Once you have amended this statement in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting original paper that quantifies with statistical analysis the improvement in diagnostic performance of the TOF-MRA combined with 3D-PD MRI with respect to the TOF-MRA performed alone for the identification of aneurysms and infundibula from the detected lesions in the circle-of-Willis. DSA is used as reference standard to verify the diagnostic outcomes. The methodology and the statistics are sufficiently detailed, and the study is properly placed in the context. The Authors clearly expose the motivation for this study and its use in the context of lifting the patient from the fear and anxiety due to the knowledge of having an aneurysm, when the probability of that lesion actually being an infundibulum is not negligible. Also, the proposed technique is completely non-invasive and would offer additional diagnostic capabilities by using it to complement other non-invasive techniques such as TOF-MRA, which used alone would have lower performance. This is an important aspect to take into consideration, since the gold standard alternative of the DSA carries important risks, as explained by the authors. The image acquisition details used for the different diagnostic techniques are extensively provided by the Authors. However, it would be nice if more information could be added about the use of different imaging parameters with the same technique and in between the techniques, specifying if the changes are compatible with the possibility of a comparison between the techniques in terms of diagnostic capabilities. For example, can a possible change in resolution have affected the results? A few comments for consideration: 1) At line 317 in the Discussion section the Authors mention that the time elapsed between the PD MRI and the DSA is variable and in some cases up to 6 months. Would it be possible to add an additional comment specifying how this variation could have significantly or not affected the results? I believe it would also be important at this point to refresh the memory of the readers about the fact that the TOF-MRA and 3D-PD MRI have been performed simultaneously, thus the main comparison between TOF-MRA alone and TOF-MRA combined with 3D-PD MRI is not affected by this time issue. Regarding the comparison with DSA instead, which would be affected by the time issue, my understanding is that if DSA was performed afterwards, and only a worsening of the situation can be considered with time, the calculated performance compared to DSA could have only been better than the shown results in the case where the DSA had been performed without waiting a long time. 2) At line 7, term “index lesions”. I see the Authors give a definition of the term at line 80 in the Introduction section but, using this term in the abstract without a definition seems confusing to me. I would suggest providing an explanation for this from the beginning. 3) Multiple times throughout the manuscript the Authors use the term “differentiating”. An instance can be found at line 81. The word "differentiating" as it is used in the sentences leads me to think that the Authors want to differentiate between the aneurysm and the index lesion, while they are actually identifying which of the index lesion is an aneurysm or an infundibulum. Therefore, I would rather use the word identifying, by saying "identifying the true unruptured aneurysms among the index lesions". 4) Line 14, “Three neuroradiologists”: after reading this in the abstract, it was confusing for me to find more people mentioned in the Materials and Methods section under Image Analysis. 5) Line 16: Is the parenthesis an explanation of what the Authors mean with aneurysm, differently from the infundibula from which instead vessel originates? As it is positioned in the sentence, it seems instead referring to the definition of index lesions. 6) End of the line 18: I think there is an “of” that would need to be deleted. 7) At line 26 and 27 the Authors use the terms “superior” and “lower”. I would suggest adding a quantification to these terms. 8) At line 57, I would suggest adding literature citations to support the two previous sentences. 9) At line 78 the Authors mention that to their knowledge, no previous study has reported the use of vessel wall MRI in differentiating intracranial aneurysms from the lesions suspected of being aneurysms. I found a few interesting papers on the topics that may be worth referencing, even if not necessarily at line 78: DOI: 10.7461/jcen.2015.17.3.180 DOI: 10.1136/neurintsurg-2019-015149 DOI: https://doi.org/10.3174/ajnr.A6080 DOI: https://doi.org/10.3174/ajnr.A4893 10) At line 104 the acronym “ICA” is used by the Authors, however I could not find an explanation of what the acronym stands for in the text of the manuscript. 11) Sentence starting at line 106 “Index lesions with an ophthalmic artery origin are lesions that appeared to be in contact with the ophthalmic arteries on volume-rendered TOF-MRA images.” Could the Authors clarify the purpose of this sentence and the connection to the previous and following sentences? 12) Table 1: • Please correct the alignment of the words “Index lesions” and “Aneurysms” in the two columns. • Under the columns referring to “Size without ophthalmic artery origin”, how were the new totals (100% of the 2 columns below) calculated? • Under the columns referring to “Size without ophthalmic artery origin”, the second column total doesn’t add up to 100. • Under “Location”, the second column total doesn’t add up to 100. 13) At line 119, I would suggest the word “machines” to be substituted with the word “systems”. 14) From line 126 to 128, please check the units. Why do the matrix dimensions have a unit of mm (as per my experience it should be unitless)? FOV unit should be mm^3, as well as for voxel size. Same suggestions for line 137 to 140. 15) At lines 148-150, please check the units and dimensions. 16) At line 160 the Authors mention that the neuroradiologists reviewed the images, but it is not specified how many times they reviewed them. I believe adding this information would make clearer how the total of 1356 observations was obtained. I inferred the total from Table 2; however I couldn’t find it throughout the text. 17) At line 281 the Authors use the term “good”. I would suggest choosing a different word, as “good” can be considered as a subjective (non-quantitative) term. Reviewer #2: The study investigates the additional diagnostic value of 3D Proton Density Imaging in the evaluation of indeterminate vessel wall lesions. The technique seems interesting in this context, as high resolution PD-vessel images can potentially be achieved at a reasonable acquisition time (at least in 2/3 protocols). The study, although retrospective, seems to have been carried out thoroughly and certainly includes a large number of cases, which allows a statement about the method. The study needs a fundamental revision, in particular because important references were not mentioned, which need to be addressed. 1) The study does not mention that recently a very similar study involving PD imaging has been published (first study from Seoul): Kim S, Chung J, Cha J, et al. Usefulness of high-resolution three-dimensional proton density-weighted turbo spin-echo MRI in distinguishing a junctional dilatation from an intracranial aneurysm of the posterior communicating artery: a pilot study. Journal of NeuroInterventional Surgery 2020;12:315-319 Seon Jin Yoon, Na-Young Shin, Jae Whan Lee, Seung Kon Hu and Keun Young Park. Localization and Treatment of Unruptured Paraclinoid Aneurysms: A Proton Density MRI-based Study. J Cerebrovasc Endovasc Neurosurg. 2015;17(3):180-184 The study submitted here must indicate whether it is a patient cohort independent of the above-mentioned studies (concern about dual publication). The study seems to go beyond these publications both in terms of the location of the lesions and the number of cases. Please comment on the progress of your study compared to these studies. 2) L3-4: The Background paragraph needs rephrasing 3) The detection and confidence of aneurysm/infundibulum visualization is certainly a function of spatial resolution. This should be adressed in the introduction and discussion sections. TOF MRA benefits from compressed-sense techniques, improving spatial resolution at reasonable scan times. This should be adressed in the discussion, as the presented TOF technique seems not to represent latest state-of-the art technique. Please do include current references on TOF MRA imaging. 4) Is it possible to define a technique-dependent cutoff-value regarding aneurysm size based on the ROC-analysis? I suppose that this is complicated by the different resolution being used/clustered data but would increase the value of the study, as probably smaller aneurysms were detectable with additional PD-sequence compared to TOF alone. Otherwise, it would be necessary to address the different spatial resolutions being used instead of performing a pooled analysis, the cohort size should allow this to be done. 5) Tables 2-4 need reformatting; e.g. fuse tables 3 and 4 6) L283-284: needs rephrasing, with this sentence the mentioned study is not adequately cited 7) L290-292: please change this sentence and also adress Kim S et al. Journal of NeuroInterventional Surgery 2020;12:315-319 8) L295-298: Please mention the spatial resolution/voxel size, which seems smaller compared to TOF MRA. Hypothesis: does PD MRA benefit from true isotropic acquisition (compared to TOF?) and higher CNR? 9) Please also adress aneurysm location (e.g. skull base, ca) as a relevant factor regarding aneurysm detection in the discussion section. Was detectability of „true“ aneurysms higher in these locations when using additional PD? 10) The ROC-curves are not being presented in the study, would certainly improve its value. 11) Please revise figures 1-3: mention image planes in the figure legend. The illustrations also need a general didactic revision with regard to the recognizability of the pathology. a. Fig. 1: a,b please zoom in; 1c-h mention image plane in the figure legend b. Fig. 2: c-j mention image plane in the figure legend c. Fig. 3: a,b please zoom in; c-j mention image plane in the figure legend ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Added diagnostic values of three-dimensional high-resolution proton density-weighted magnetic resonance imaging for unruptured intracranial aneurysms in the circle-of-Willis: Comparison with time-of-flight magnetic resonance angiography. PONE-D-20-13596R1 Dear Dr. Jung, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Nicola Toschi Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: no further comments............................................................................................................. Reviewer #2: The authors adressed all my comments and recommendations. I only recommend correct reading by a native speaker. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-13596R1 Added diagnostic values of three-dimensional high-resolution proton density-weighted magnetic resonance imaging for unruptured intracranial aneurysms in the circle-of-Willis: Comparison with time-of-flight magnetic resonance angiography Dear Dr. Jung: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Nicola Toschi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .